Novartis AG
ISIN
CH0012005267
Ticker
NOVN
Sector
Sub-Industry
Country
Switzerland
Year Founded
1859
ISIN
CH0012005267
Ticker
NOVN
Sector
Sub-Industry
Country
Switzerland
Year Founded
1859
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.
Innovative Medicines
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
110,000
Worldwide
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 25.04.2024 | None | Executive member | Sell | CHF 4,976,228.62 |
| 25.04.2024 | None | Executive member | Sell | CHF 1.00 |
| 05.03.2024 | None | Non-Executive member | Buy | CHF 210,000.00 |
| 05.03.2024 | None | Non-Executive member | Buy | CHF 180,000.00 |
| 05.03.2024 | None | Non-Executive member | Buy | CHF 97,500.00 |
| 05.02.2024 | None | Executive member | Sell | CHF 76,577.27 |
| 02.02.2024 | None | Executive member | Sell | CHF 1,358,618.79 |
| 02.02.2024 | None | Executive member | Sell | CHF 160,484.80 |
| 30.01.2024 | None | Executive member | Buy | CHF 1,157,807.87 |
| 30.01.2024 | None | Executive member | Buy | CHF 417,611.45 |
CH0012005267
5493007HIVTX6SY6XD66
SMI
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.